Genprex, Inc. Files 8-K with Regulatory and Financial Updates
Ticker: GNPX · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1595248
Sentiment: neutral
Topics: regulatory-disclosure, financial-statements
Related Tickers: GNPX
TL;DR
Genprex filed an 8-K on Aug 4, 2025, covering Reg FD and financials. Check it out.
AI Summary
Genprex, Inc. filed an 8-K on August 4, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD Disclosure and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in Austin, Texas.
Why It Matters
This 8-K filing provides important updates on Genprex, Inc.'s regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for regulatory and financial updates and does not appear to contain significant new risks.
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- August 4, 2025 (date) — Date of report
- Austin, Texas (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Genprex, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits, as of August 4, 2025.
When was Genprex, Inc. incorporated and in which state?
Genprex, Inc. was incorporated in Delaware.
What is the business address of Genprex, Inc.?
The business address of Genprex, Inc. is 3300 Bee Cave Road, #650-227, Austin, TX 78746.
What is the telephone number for Genprex, Inc.?
The telephone number for Genprex, Inc., including area code, is (512) 537-7997.
What is the Standard Industrial Classification code for Genprex, Inc.?
The Standard Industrial Classification code for Genprex, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Genprex, Inc. (GNPX).